The Global Heart Blocks Treatment Devices Market size is anticipated to grow at a CAGR of 7.5% and is expected to reach USD 5.1 billion by 2028, The major factors driving the market include increasing prevalence of cardiac diseases, rising adoption of minimally invasive surgical techniques, and technological advancements in implantable devices for heart blocks treatment.
Heart Block Treatment Devices are any medical devices or instruments that help to treat heart blockages in which the electrical signals cannot be transmitted properly from the atria to ventricles. These treatments for blocks can include pacemakers, catheters, and ablation techniques. These devices are used to treat an abnormal heart rhythm. Heart Blocks Treatment Devices includes devices like pacemakers, implantable cardioverter-defibrillators (ICDs), automated external defibrillator (AEDs), and implantable rate regulators that are implanted in the body for treating patients with arrhythmia. Treatment of all these abnormal rhythms is done by electrical impulses generated from a device fitted either externally on the chest or internally near the heart.
On the basis of Type, the market is segmented into SA Node Nodal Block (Sinoatrial node), AV Node Nodal Block (Atrioventricular node).
SA node block is a temporary disruption of the electrical impulses that make up the heart's rhythm. A SA node nodal block happens when one or more natural pacemaker cells in the upper right chamber of the heart, known as sinus nodes, are not functioning properly. The lack of impulse to these cells disrupts their ability to send signals for contractions throughout other parts of the heart and creates irregular rhythms that may be life-threatening if left untreated.
The SA node sends signals to both ventricles of the heart through one bundle of fibers called His-Purkinje System or Bundle Of Kent. This system helps in the contraction and relaxation of the ventricular myocardium which is located on either side of a muscular septum that separates left from right chambers. Abnormalities such as congenital defects can result in an excessive electrical activity by cells near the SA node or tissue death due to injury may lead to conduction abnormalities at this site resulting in SA node block.
AV Node Nodal Block can be defined as a blockage of signals from the heart to prevent it from contracting. This can be because of a problem with the electrical impulse or mechanical obstruction in one of its conduction pathways. The AV node is located in the lower mid-portion of the heart. The electrical impulse from the sinoatrial (SA) node spreads to both ventricles and splits before entering them. It then stimulates the contraction of these chambers so that blood gets pumped into circulation.
The AV node sends a signal to both ventricles of the heart through one bundle of fibers called Bundle Of His or Bundle Of Kent which helps in contraction and relaxation of the cardiac myocardium located on either side of the muscular septum that separates left from right chambers. Congenital defects such as excessive electrical activity by cells near SA nodes, tissue death due to injury may lead to conduction abnormalities at this site resulting in AV nodal blocks.
On the basis of Application, the market is segmented into Hospitals and Clinics. Heart Block Treatment Devices are also used in clinics for various reasons. These devices help to restore normal heartbeat rates, and they can be used as an alternative when other treatments have failed. In some cases, physicians use these devices on patients who suffer from arrhythmia or irregular heartbeats that don't allow the person to lead a regular life. They may also be prescribed if electrical impulses are not being transmitted through the AV node properly due to disease or injury.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The heart block treatment devices market is projected to grow substantially in the coming years due to the rising prevalence of arrhythmias globally.
The North American market is projected to grow at a moderate pace in the coming years. The US market accounted for an approximated 73% share of revenue, growing significantly from its original level, owing to new product launches by key players during 2017-2018.
The Europe region will account for about 35% share in terms of volume and value when compared to other regions globally with a strong presence in countries like Germany followed closely by France, Italy, and Spain, etc., reaching over 20%. The Asia Pacific dominated the global Heart Block Devices Market accounting for 47%, owing to increasing prevalence rates among individuals faced with cardiac arrhythmias as well as high median age population coupled with rising awareness levels & access.
Contributing factors to the growth of this market are increasing prevalence rates, high growth in emerging markets, and technological advancements. Increasing prevalence rates for heart block treatment devices is an important factor that influences the demand for these products. The global increase in the number of patients being diagnosed with a heart block has contributed to higher usage rates than previously thought due to more effective treatments available today such as pacemakers or implantable defibrillators. As well as increased awareness of conditions leading up to a heart-block diagnosis by healthcare professionals and growing incidence rates thereof globally; there will be an upward trend in the use of drugs that have been introduced recently, like new generations beta-blockers, digitalis derivatives, or calcium channel blockers among others. These all contribute towards the growth of this market in the foreseeable future.
Up Market Research published a new report titled “Heart Blocks Treatment Devices Market research report which is segmented by Types (Sinoatrial node (SA node) nodal block, Atrioventricular node (AV node) nodal block), By Applications (Hosptial, Clinic), By Players/Companies Medtronic, Inc., Boston Scientific Corporation, Abbott, BIOTRONIK SE & Co. KG, SORIN S.p.A.”.
|Report Attributes||Report Details|
|Report Title||Heart Blocks Treatment Devices Market Research Report|
|By Type||Sinoatrial node (SA node) nodal block, Atrioventricular node (AV node) nodal block|
|By Application||Hosptial, Clinic|
|By Companies||Medtronic, Inc., Boston Scientific Corporation, Abbott, BIOTRONIK SE & Co. KG, SORIN S.p.A.|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||238|
|Number of Tables & Figures||167|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Sinoatrial node (SA node) nodal block, Atrioventricular node (AV node) nodal block and By Application Hosptial, Clinic.
Some of the companies that are profiled in this report are:
Heart Blocks Treatment Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Heart Blocks Treatment Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Heart Blocks Treatment Devices Market Report:
Some other reports from this category!